Cook Medical Sizing Catheters Removed Due to Risk of Device Breakage
The U.S. Food and Drug Administration (FDA) has issued an early alert regarding a potentially serious device issue involving certain sizing catheters manufactured by Cook Medical.
Cook Medical has notified customers to immediately remove affected products from use and distribution due to a risk of device component failure that could result in patient harm.
Affected Devices
The recall involves Centimeter Sizing Catheters, Aurous Centimeter Sizing Catheters, and Beacon Tip Centimeter Sizing Catheters. Download a full list of affected product lots by clicking on the download link in the right column of this page.
Device Use
Sizing catheters are used in angiographic procedures by trained physicians to navigate vascular anatomy, accurately position devices, and measure anatomical structures.
They are available in lengths of 70 cm and 100 cm, and tip configurations including straight, PIG, and VCF.
Reason for the Alert
Cook Medical identified that marker bands on the affected catheters may be prone to cracking or breakage.
These marker bands are critical for device positioning and anatomical orientation during angiographic procedures
Potential Risks to Patients
If a device failure occurs, potential adverse events may include increased procedural time, device fragmentation or separation, vessel injury, and the need for additional intervention.
In severe cases, device fragmentation could lead to life-threatening complications or death.
As of April 2, no serious injuries or deaths have been reported.
Required Actions for Healthcare Providers
Cook Medical has instructed customers to take the following steps immediately.
Identify and Quarantine
Review inventory for affected products and remove then isolate any impacted devices.
Cease Use and Distribution
Do not use affected catheters and stop any further distribution.
Return Affected Products
Return affected products to Cook Medical.
Notify Internal and External Stakeholders
Inform all relevant personnel and any facilities that received the devices.
Report Adverse Events
Adverse events or quality issues should be reported to Cook Medical by phone at 800.457.4500 / 812.339.2235, or by email at CustomerRelationsNA@CookMedical.com.
Healthcare providers may also report events through the FDA’s MedWatch program.
Regulatory Status
The FDA is currently evaluating this issue and has classified it as an early alert, indicating a potentially high-risk device concern. Further updates will be provided as additional information becomes available.
MDP Insight
This event highlights several critical quality system considerations. Supplier and component control failures can directly impact device integrity. Design robustness and material durability must be validated under real-world conditions. Postmarket surveillance systems must detect early signals of failure, and CAPA systems must rapidly assess and mitigate risk.
Marker band failure represents an intersection between design, manufacturing, and risk management.
Key Takeaway
Even seemingly minor components like marker bands can create significant clinical risk if they fail. This reinforces the importance of comprehensive design validation, robust supplier controls, and effective postmarket monitoring.
Links
Read the FDA’s announcement here.
Download the List of Affected Products
Pharmacal Recalls MG217 Eczema Cream
Pharmacal Recalls MG217 Eczema Cream Due to Staphylococcus aureus ContaminationFDA posts nationwide recall after microbial contamination found in topical skin treatment Pharmacal has voluntarily recalled one lot of MG217 Multi-Symptom Treatment Cream & Skin...
Cefazolin Injection Recalled Due to Cardboard in Sterile IV Solution
Baxter Recalls Cefazolin Injection Sterile IV SolutionCardboard Particulate Matter Found in a Sterile Intravenous Infusion Bag Baxter International has voluntarily recalled one lot of Cefazolin in Dextrose Injection, USP, 2 g/100 mL after a report of cardboard...
Editorial: Two Days Later, Another Moringa Recall
Recurring Moringa Recalls Highlight Ongoing Supply Chain Concerns On July 17, the U.S. Food and Drug Administration officially closed its investigation into a multistate Salmonella outbreak linked to MOGO-brand moringa capsules. The outbreak was not insignificant....
Moringa Capsules Recalled for Potential Salmonella Contamination
Zen Principle Recalls Moringa Capsules After FDA Detects Salmonella in Raw Ingredient Relay Peak Research LLC, doing business as Zen Principle Naturals, has voluntarily recalled one lot of its Zen Principle® Moringa Capsules after learning that the raw moringa leaf...
Eight Months of Moringa Salmonella Outbreaks
Recurring Salmonella Outbreaks Raise Questions About Supplement Oversight Since November 2025, the U.S. Food and Drug Administration has investigated and coordinated multiple recalls involving moringa dietary supplements contaminated with Salmonella. What initially...
FDA Closes Moringa Salmonella Outbreak Investigation
The U.S. Food and Drug Administration and the Centers for Disease Control and Prevention have concluded their investigation into a multistate Salmonella Typhimurium outbreak linked to MOGO-brand moringa powder capsules distributed by MOGO Moringa LLC of St. Louis,...